RE: WSG share price just waking up?10 Apr 2024 07:33
The video of the new Kinshasa financial centre looks nice. Fowler seems happy but slightly disorientated- thankfully he emphasised the DRC initials to confirm for newbies (and himself) which country he is in
The reality of dealing with disgruntled (and poorly treated) RVA customs officers in provincial airports will be different- they burned down some of the offices in 2021. Also Shungu (RVA chief) has been removed without due process in recent weeks- it’s a shame- he was doing a good job
Alphonse shungu, previous head of the RVA in DRC is under investigation for various alleged misdemeanours. He has been removed from his position in dec 23 and replaced with new management- he is unable to leave the country on government orders
WSG have hoped to take over the customs division of RVA since June 2021- they have negotiated the deal with 3 RVA leads who have either been imprisoned or are under criminal investigation
Lawrence was adjudged in the ruling to have been aware of the widespread culture and practice of ‘ghosting’ at keyguard- not a great advert for their services if he remains CEO
Fowler has fattened himself on placing money and is in deep deep cyber-hibernation hoping for an awakening- he has sent out his tema podcast on an intergalactic spaceship hoping alien life will pick it up and require Wsg services in distant decades- he is working bloody hard to get these deals over the line
Nigel is a good communicator but not a engineer, scientist or doctor
As with all early stage entrepreneurs he has to convince investors to trust him in speculative tech
Unfortunately the reformulation division was a hopeless venture in which the main achievement was tens of patents for multiple reformulated generic drugs which the original pharma behemoths had no interest in reformulating themselves. Nigel was able to convince some of the people here that he could achieve something Pfizer et Al could not do. He hopelessly failed
She is a scientific advisor to nanogenics- she is not on the board however. They estimate 15
Months to human trials- it’s unclear if this will be achieved- the original paper and positive findings date from 2016. However the delivery particle seems easy to manufacture without significant side effects- at least in the rabbit model